EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Camurus AB's enterprise value is €2,601.1 Mil.
Camurus AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €158.2 Mil. Therefore, Camurus AB's EV-to-Revenue for today is 16.44.
The historical rank and industry rank for Camurus AB's EV-to-Revenue or its related term are showing as below:
FRA:7CA'
s EV-to-Revenue Range Over the Past 10 Years
Min: 9.1 Med: 32 Max: 97.06
Current: 16.68
During the past 13 years, the highest EV-to-Revenue of Camurus AB was 97.06. The lowest was 9.10. And the median was 32.00.
FRA:7CA's EV-to-Revenue is ranked worse than 64.17% of 1041
companies
in the Biotechnology industry
Industry Median: 8.07
vs FRA:7CA: 16.68
As of today (2024-05-16), Camurus AB's stock price is €47.78.
Camurus AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €2.74. Therefore, Camurus AB's PS Ratio for today is 17.46.
Camurus AB EV-to-Revenue Historical Data
The historical data trend for Camurus AB's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Camurus AB's EV-to-Revenue
For the Biotechnology subindustry, Camurus AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camurus AB's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Camurus AB's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Camurus AB's EV-to-Revenue falls into.
Camurus AB's current Enterprise Value is €2,601.1 Mil.
Camurus AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €158.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camurus AB's share price for today is €47.78.
Camurus AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.74.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camurus AB EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Camurus AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:7CA has been successfully added to your 